naltrexone

Abstract Importance In 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing...

Abstract Importance Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist. Objective To evaluate an implementation intervention over 2 years to...

Abstract Background The use of naltrexone plus bupropion to treat methamphetamine use disorder has not been well studied. Methods We conducted this multisite, double-blind, two-stage, placebo-controlled trial with the use of a sequential...

See this message as a web page THE PLACEBO EFFECT *IS* THE MAIN ACTIVE INGREDIENT Medications featured prominently in row 3 of the Alcohol Treatment Matrix on the medical treatment of alcohol dependence. Yet in the first cell we learnt that...

View this message as a web page DRINK, DOCTORS AND MEDICATIONS Time to consolidate the lessons of the five cells of row 3 in the Alcohol Treatment Matrix, all on the treatment of alcohol dependence in a medical context or involving medical...

View this message as a web page: DRINK, DOCTORS AND MEDICATIONS Time to consolidate the lessons of the five cells of row 3 in the Alcohol Treatment Matrix, all on the treatment of alcohol dependence in a medical context or involving medical...

MAKING THE MOST OF MEDICAL CARE Selected, explained and discussed – key research on management of medical interventions and treatment in medical settings. Highlights the remarkable transformation of a US clinic in the 1950s by an open...

‘BEDSIDE’ MANNER MATTERS The previous cell of the Alcohol Treatment Matrix looked mainly at the medications clinicians prescribe. Now we look at the clinicians themselves, and discover that for this ‘disease’, bedside manner is not just a...

DOCTORS AND DRUGS; MEDICAL TREATMENT OF DEPENDENT DRINKING Seminal and key research selected, explained and explored. First cell of row three enters the domain of doctors and drugs, starting with the study from 1970s London bold enough to...